Myosin heavy chain-perinatal regulates skeletal muscle differentiation, oxidative phenotype and regeneration

Area of Science:

• Muscle biology
• Developmental biology
• Regenerative medicine

Background:

• Myosin heavy chain-perinatal (MyHC-perinatal) is crucial for skeletal muscle development and regeneration.
• Mutations in MyHC-perinatal are linked to contracture syndromes like Trismus-pseudocamptodactyly syndrome.
• The precise functions of MyHC-perinatal remain largely undefined.

Purpose of the Study:

• To elucidate the functional roles of MyHC-perinatal in skeletal muscle differentiation and regeneration.
• To investigate the molecular mechanisms underlying MyHC-perinatal's influence on muscle development.
• To understand the implications of MyHC-perinatal dysfunction in muscle disorders.

Main Methods:

• In vitro studies of skeletal muscle differentiation with MyHC-perinatal loss of function.
• Proteomic analysis to identify metabolic and signaling pathway alterations.
• In vivo studies using knockdown models during muscle regeneration.
• Analysis of myogenic regulatory factors, fiber type markers, and cell populations.

Main Results:

• Loss of MyHC-perinatal function enhances in vitro differentiation and shifts myofiber metabolism from oxidative to glycolytic.
• Paracrine signaling, including caspase-3 and NF-κB pathways, mediates the effects of MyHC-perinatal loss.
• In vivo MyHC-perinatal knockdown impairs muscle regeneration, leading to smaller myofibers, fibrosis, and reduced satellite cells.
• MyHC-perinatal is identified as a key regulator of myogenic differentiation, myofiber oxidative phenotype, and regeneration.

Conclusions:

• MyHC-perinatal is essential for regulating skeletal muscle differentiation and maintaining myofiber oxidative characteristics.
• The protein plays a critical role in the regenerative capacity of skeletal muscle.
• Understanding MyHC-perinatal's function offers insights into muscle development, regeneration, and associated diseases.